Fundamental Equity Fund
Daily price w/o sales charge as of 04/22/2019
$12.32
$0.02
YTD Returns w/o sales charge as of 04/22/2019
13.76%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of U.S. companies.
Fund Basicsas of 03/29/2019
- Total Net Assets
- $2.42 B
- Inception Date
- 07/15/1996
- Dividend Frequency
- Annually
- Number of Holdings
- 68
- Minimum Initial Investment
- $1,500+
Expense Ratioas of 03/31/2019
Yield
12-Month Dividend Yield 1 as of 04/22/2019
| w/o sales charge | 1.43% |
| w/ sales charge | 1.35% |
30-Day Standardized Yield 2 as of 03/31/2019
| 1.37% |
Fund Expense Ratio :
0.96%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/15/1996 |
|---|
| w/o sales charge | 10.90% | 4.10% | 10.06% | 6.53% | 12.61% | 9.54% |
| Lipper Category Avg. Large-Cap Value Funds | 11.50% | 4.45% | 10.30% | 7.10% | 13.56% | - |
| Russell 1000® Value Index | 11.93% | 5.67% | 10.45% | 7.72% | 14.52% | 8.84% |
| w/ sales charge | 4.53% | -1.88% | 7.89% | 5.27% | 11.95% | 9.25% |
Fund Expense Ratio :
0.96%
Fund Expense Ratio :
0.96%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/15/1996 |
|---|
| w/o sales charge | 10.90% | 4.10% | 10.06% | 6.53% | 12.61% | 9.54% |
| Lipper Category Avg. Large-Cap Value Funds | 11.50% | 4.45% | 10.30% | 7.10% | 13.56% | - |
| Russell 1000® Value Index | 11.93% | 5.67% | 10.45% | 7.72% | 14.52% | 8.84% |
| w/ sales charge | 4.53% | -1.88% | 7.89% | 5.27% | 11.95% | 9.25% |
Fund Expense Ratio :
0.96%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance of future results.
TEN LARGEST HOLDINGS as of 03/29/2019View Portfolio
| Holding | Assets |
|---|---|
| Johnson & Johnson, Inc. | 3.9% |
| JPMorgan Chase & Co. | 3.7% |
| Bank of America Corp. | 3.5% |
| Merck & Co., Inc. | 3.3% |
| Verizon Communications, Inc. | 2.8% |
| Wells Fargo & Co. | 2.6% |
| Pfizer, Inc. | 2.6% |
| Citigroup, Inc. | 2.5% |
| PepsiCo, Inc. | 2.4% |
| United Technologies Corp. | 2.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 03/29/2019View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
12-Month Dividend Yield 1 as of 04/22/2019
| w/o sales charge | 1.43% |
| w/ sales charge | 1.35% |
30-Day Standardized Yield 2 as of 03/31/2019
| Subsidized5 | Un-Subsidized6 | |
|---|---|---|
| w/o sales charge | 1.37% | 1.37% |
In absence of the fee waiver, yields shown would have been lower. Yields for other share classes will vary.
Fund Expense Ratio :
0.96%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/15/1996 |
|---|
| w/o sales charge | 10.90% | 4.10% | 10.06% | 6.53% | 12.61% | 9.54% |
| Lipper Category Avg. Large-Cap Value Funds | 11.50% | 4.45% | 10.30% | 7.10% | 13.56% | - |
| Russell 1000® Value Index | 11.93% | 5.67% | 10.45% | 7.72% | 14.52% | 8.84% |
| w/ sales charge | 4.53% | -1.88% | 7.89% | 5.27% | 11.95% | 9.25% |
Fund Expense Ratio :
0.96%
Fund Expense Ratio :
0.96%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/15/1996 |
|---|
| w/o sales charge | 10.90% | 4.10% | 10.06% | 6.53% | 12.61% | 9.54% |
| Lipper Category Avg. Large-Cap Value Funds | 11.50% | 4.45% | 10.30% | 7.10% | 13.56% | - |
| Russell 1000® Value Index | 11.93% | 5.67% | 10.45% | 7.72% | 14.52% | 8.84% |
| w/ sales charge | 4.53% | -1.88% | 7.89% | 5.27% | 11.95% | 9.25% |
Fund Expense Ratio :
0.96%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance of future results.
| Year | Fund Returns | Russell 1000® Value Index |
|---|
| 2018 | -8.45% | -8.27% |
| 2017 | 12.97% | 13.66% |
| 2016 | 15.74% | 17.34% |
| 2015 | -3.14% | -3.83% |
| 2014 | 6.93% | 13.45% |
| 2013 | 36.63% | 32.53% |
| 2012 | 10.74% | 17.51% |
| 2011 | -3.92% | 0.39% |
| 2010 | 19.21% | 15.51% |
| 2009 | 25.86% | 19.69% |
| 2008 | -28.75% | - |
| 2007 | 7.48% | - |
| 2006 | 13.64% | - |
| 2005 | 5.48% | - |
| 2004 | 15.61% | - |
| 2003 | 31.93% | - |
| 2002 | -14.41% | - |
| 2001 | -4.20% | - |
| 2000 | 9.27% | - |
| 1999 | 20.29% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2019 | 10.90% | - | - | - | 13.76% |
| 2018 | -2.47% | -0.55% | 6.29% | -11.19% | -8.45% |
| 2017 | 1.55% | 2.21% | 3.13% | 5.54% | 12.97% |
| 2016 | -0.42% | 4.69% | 3.83% | 6.93% | 15.74% |
| 2015 | -0.45% | 0.82% | -8.73% | 5.73% | -3.14% |
| 2014 | 0.20% | 2.87% | 0.00% | 3.74% | 6.93% |
| 2013 | 13.37% | 3.49% | 6.15% | 9.70% | 36.63% |
| 2012 | 11.31% | -6.90% | 5.18% | 1.59% | 10.74% |
| 2011 | 6.50% | -0.94% | -19.59% | 13.26% | -3.92% |
| 2010 | 6.44% | -10.72% | 10.55% | 13.47% | 19.21% |
| 2009 | -8.56% | 12.91% | 16.14% | 4.96% | 25.86% |
| 2008 | -7.52% | 1.24% | -8.38% | -16.94% | -28.75% |
| 2007 | 2.19% | 5.79% | 2.10% | -2.62% | 7.48% |
| 2006 | 7.63% | -0.24% | 1.18% | 4.59% | 13.64% |
| 2005 | -2.00% | -0.17% | 5.87% | 1.84% | 5.48% |
| 2004 | 3.22% | 1.38% | -0.36% | 10.88% | 15.61% |
| 2003 | -3.21% | 15.84% | 2.98% | 14.27% | 31.93% |
| 2002 | 3.62% | -8.89% | -14.47% | 6.00% | -14.41% |
| 2001 | -7.84% | 5.38% | -8.91% | 8.29% | -4.20% |
| 2000 | -1.63% | -2.39% | 6.22% | 7.14% | 9.27% |
| 1999 | 3.62% | 10.89% | -6.04% | 11.41% | 20.29% |
| 1998 | 10.30% | -0.68% | -11.22% | 18.71% | 15.47% |
| 1997 | 1.97% | 14.32% | 6.43% | 2.93% | 27.70% |
| 1996 | - | - | - | 8.70% | 18.60% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV HISTORICAL PRICES
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Johnson & Johnson, Inc. | Health Care | 3.9% |
| JPMorgan Chase & Co. | Financials | 3.7% |
| Bank of America Corp. | Financials | 3.5% |
| Merck & Co., Inc. | Health Care | 3.3% |
| Verizon Communications, Inc. | Communication Services | 2.8% |
| Wells Fargo & Co. | Financials | 2.6% |
| Pfizer, Inc. | Health Care | 2.6% |
| Citigroup, Inc. | Financials | 2.5% |
| PepsiCo, Inc. | Consumer Staples | 2.4% |
| United Technologies Corp. | Industrials | 2.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Johnson & Johnson, Inc. | Health Care | 3.9% |
| Bank of America Corp. | Financials | 3.9% |
| JPMorgan Chase & Co. | Financials | 3.8% |
| Merck & Co., Inc. | Health Care | 3.2% |
| Verizon Communications, Inc. | Communication Services | 2.7% |
| Wells Fargo & Co. | Financials | 2.7% |
| Pfizer, Inc. | Health Care | 2.7% |
| Citigroup, Inc. | Financials | 2.6% |
| United Technologies Corp. | Industrials | 2.4% |
| PepsiCo, Inc. | Consumer Staples | 2.3% |
| Wal-Mart Stores, Inc. | Consumer Staples | 2.1% |
| Chevron Corp. | Energy | 2.1% |
| ACE Ltd. | Financials | 2.1% |
| ProLogis, Inc. | Real Estate | 2.0% |
| Walt Disney Co. | Communication Services | 1.9% |
| Intel Corp. | Information Technology | 1.9% |
| Microsoft Corp. | Information Technology | 1.9% |
| Marathon Petroleum Corp. | Energy | 1.8% |
| Hartford Financial Services Group, Inc. | Financials | 1.8% |
| Oracle Corp. | Information Technology | 1.7% |
| Cisco Systems, Inc. | Information Technology | 1.7% |
| Royal Dutch Shell plc | Energy | 1.7% |
| TJX Cos., Inc. | Consumer Discretionary | 1.6% |
| Suncor Energy, Inc. | Energy | 1.6% |
| Axis Capital Holdings Ltd. | Financials | 1.5% |
| Anthem, Inc. | Health Care | 1.5% |
| Stanley Black & Decker, Inc. | Industrials | 1.5% |
| Apple, Inc. | Information Technology | 1.5% |
| Edison International | Utilities | 1.5% |
| Masco Corp. | Industrials | 1.5% |
| Noble Energy, Inc. | Energy | 1.5% |
| DowDuPont Inc | Materials | 1.4% |
| Alphabet, Inc. | Communication Services | 1.4% |
| Abbott Laboratories | Health Care | 1.3% |
| AMETEK, Inc. | Industrials | 1.3% |
| Hewlett-Packard Co. | Information Technology | 1.3% |
| East West Bancorp, Inc. | Financials | 1.2% |
| Foot Locker, Inc. | Consumer Discretionary | 1.2% |
| Avnet, Inc. | Information Technology | 1.1% |
| Hubbell, Inc. | Industrials | 1.1% |
| Lear Corp. | Consumer Discretionary | 1.1% |
| Philip Morris International, Inc. | Consumer Staples | 1.1% |
| Allergan plc | Health Care | 1.1% |
| NextEra Energy, Inc. | Utilities | 1.1% |
| Nucor Corp. | Materials | 1.1% |
| Unilever N.V. | Consumer Staples | 1.1% |
| The Royal Bank of Scotland Group PLC | Financials | 1.1% |
| National Oilwell Varco, Inc. | Energy | 1.0% |
| Simon Property Group, Inc. | Real Estate | 1.0% |
| Signature Bank | Financials | 1.0% |
| Goldman Sachs Group, Inc. | Financials | 1.0% |
| Carlisle Cos., Inc. | Industrials | 0.9% |
| Coca-Cola Co. | Consumer Staples | 0.8% |
| AT&T, Inc. | Communication Services | 0.8% |
| MSC Industrial Direct Co. | Industrials | 0.8% |
| Facebook, Inc. | Communication Services | 0.7% |
| F5 Networks, Inc. | Information Technology | 0.7% |
| Duke Energy Corp. | Utilities | 0.7% |
| Gilead Sciences, Inc. | Health Care | 0.7% |
| Dollar Tree, Inc. | Consumer Discretionary | 0.7% |
| Novartis AG Registered Shares | Health Care | 0.6% |
| Steel Dynamics, Inc. | Materials | 0.6% |
| Jazz Pharmaceuticals, Inc. | Health Care | 0.6% |
| Boston Scientific Corp. | Health Care | 0.3% |
| Interpublic Group of Cos., Inc. | Consumer Discretionary | 0.3% |
| Omnicom Group, Inc. | Consumer Discretionary | 0.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 03/29/2019
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
0.6%
|
|
| Real Estate |
1.0%
|
|
| Utilities |
1.4%
|
|
| Consumer Discretionary |
 0.6%
|
|
| Consumer Staples |
0.2%
|
|
| Energy |
0.7%
|
|
| Financials |
0.6%
|
|
| Health Care |
2.0%
|
|
| Industrials |
4.8%
|
|
| Information Technology |
1.3%
|
|
| Materials |
0.8%
|
PORTFOLIO DETAILS as of 03/29/2019
- Total Net Assets
- $2.42 B
- Number of Holdings
- 68
- Weighted Average Market Cap.
- 176.3 B
- P/B Ratio
- 2.2x
- Portfolio Turnover Ratio as of 10/31/2018
- 92.2%
- P/E Ratio
- 15.4x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 03/29/2019
Contributors
| Holding | Contribution |
|---|---|
| Cisco Systems, Inc. | 0.6% |
| Bank of America Corp. | 0.5% |
| Chevron Corp. | 0.4% |
| Noble Energy, Inc. | 0.4% |
| ProLogis, Inc. | 0.4% |
Detractors
| Holding | Contribution |
|---|---|
| Pfizer, Inc. | -0.1% |
| Hewlett-Packard Co. | 0.0% |
| F5 Networks, Inc. | 0.0% |
| DowDuPont, Inc. | 0.0% |
| Biogen Idec, Inc. | 0.0% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Fundamental Equity Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to Lord Abbett Fundamental Equity Fund Performance Results for the Fund's longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 04/22/2019
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/19/2018 | 11/20/2018 | 11/20/2018 | $0.17590 | $11.47 |
Upcoming Dividend Payment Dates
This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/20/2019 | 11/21/2019 | 11/21/2019 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/19/2018 | 11/20/2018 | $0.8260 | $0.0845 | $0.9105 | $11.47 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/20/2019 | 11/21/2019 |
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 04/22/2019
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $13.07 |
| $50,000 to $99,999 | 4.75% | 4.00% | $12.93 |
| $100,000 to $249,999 | 3.95% | 3.25% | $12.83 |
| $250,000 to $499,999 | 2.75% | 2.25% | $12.67 |
| $500,000 to $999,999 | 1.95% | 1.75% | $12.57 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $12.32 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
EXPENSE RATIOas of 03/31/2019
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||